Main article:
Antibody tests
Main article: Antibodies and immunity to coronavirus COVID-19
2024: Ex-director of a medical manufacturer in Astrakhan received a term for fraud in the supply of tests for coronavirus
In August 2024, the Sovetsky District Court of Astrakhan sentenced a large-scale fraud case related to the supply of coronavirus tests. The ex-director of one of the Astrakhan companies engaged in the development and production of diagnostic products was found guilty of causing damage to the regional Ministry of Health in the amount of ₽35 million. The culprit was given a suspended sentence of imprisonment. The name of the convict, as well as the name of the company, were not disclosed in the court materials.
According to the investigation, the crime was committed between February and March 2021. As the head of the company, the accused made labeling stickers on reagent kits for detecting coronavirus RNA, in which he deliberately made false information about the shelf life of the product. Initially, the expiration date of the tests expired in April 2021, but in fake stickers it was extended until December 2021. After replacing the markings, the products were delivered to pharmacies in the region, which became the basis for initiating a criminal case.
According to GxP News, the accused fully compensated for the damage caused before the verdict, which could affect the imposition of a milder punishment on him.
This story is not the only one of its kind in the Astrakhan region. On June 5, 2024, another criminal case was completed, also related to the supply of tests for COVID-19. In 2020, the First Deputy Minister of Health of the region, acting in the interests of the director of the company, familiar to her, demanded from him charitable assistance to the department in exchange for concluding contracts for the supply of medical devices. Without auction procedures, government contracts worth more than ₽48 million were concluded. Subsequently, most of the supplied reagents were written off in 2022 due to the expiration date and their excess quantity.
According to the results of the investigation, the first deputy minister of the Ministry of Health was sentenced to five years in prison with serving in a general regime colony, and the second person involved in the case was sentenced to four years in prison. The connection between these two criminal cases is not specified.[1]
2023
2.7 million home tests for COVID-19 Roche infected with dangerous bacteria are being recalled
On May 25, 2023, the US Food and Drug Administration (FDA) announced that the South Korean biodiagnostic company SD Biosensor is forced to recall more than 2.7 million home tests for COVID-19 due to the risk of bacterial infection. Read more here.
Sistema-BioTech has developed a single test for the presence of one of 8 viral diseases in a person, including COVID-19
The scientific laboratory engaged in developments in the field of molecular biology, genetics and cellular technologies, Sistema-Biotech, on January 31, 2023, announced that it had developed a single test capable of determining in less than 30 minutes the presence of one of eight acute respiratory diseases transmitted by airborne droplets and causing mass infection of people: COVID-19 (regardless of strain), adenovirus, various types of influenza, etc. Only Russian components are used in the reagent kit of this test. Read more here.
2022: Imbian Lab has registered a rapid test for the detection of coronavirus antigen in human saliva
Imbian Lab has registered a domestic rapid test for the detection of coronavirus antigen in human saliva. This was announced on November 10, 2022 by the head of the Department of Investment and Industrial Policy of Moscow, which is part of the Complex of Economic Policy and Property and Land Relations of the capital, Vladislav Ovchinsky. Read more here.
2021
Siemens Healthineers raised 1.1 billion euros for the year from the sale of rapid tests for COVID-19
At the end of fiscal 2021 Siemens Healthineers , it gained about 1.1 billion euros from the sale of express tests for, coronavirus COVID-19 thanks to which the company was able to demonstrate a record turnover, which grew by 24.5%. If we do not take into account the mentioned tests, then revenue rose by 11.8%, which is also not bad and achieved thanks to the high performance in the departments for the production of solutions for diagnostics, medical imaging and advanced therapy. More. here
A company was created in Crimea to produce rapid tests for coronavirus and invested ₽0,5 billion in it
On October 21, 2021, it became known about the creation of the CrimeaTest company in Crimea, which will be engaged in the production of products for the rapid detection of infections in humans, including coronavirus (COVID-19). Read more here.
US government buys 187 million coronavirus tests from Abbott and Celltrion for $1.2 billion
At the end of September 2021, the US Department of Health and Human Services (HHS) announced that it would spend almost $1.2 billion on the purchase of 187 million rapid tests for the COVID-19 coronavirus from Abbott Laboratories and Celltrion. Read more here.
Sistema-Biotech began supplying tests to medical institutions to predict the severity of the course of COVID-19
On August 2, 2021, AFK Sistema announced that the biotechnological company Sistema-Biotech, which is part of the group, began supplying the first genetic test in Russia to Moscow clinics to assess the risk of COVID-19. Read more here.
Sberbank launched AI Resp app that defines COVID-19 in breathing and coughing
On May 18, 2021, Sberbank, together with SberMedAI (SberMedAI), which is part of the Sber ecosystem, launched the AI Resp application, which defines COVID-19 in breathing and coughing. Read more here.
Breathing testing systems for coronavirus appeared at Singapore airport
In mid-April 2021, breathing testing systems for COVID-19 appeared at the Singapore airport, giving results on the spot almost immediately. According to the developers, this will make it easier to organize safe travel and control infection at large-scale events. Read more here.
DARPA created a chip implantable under the skin that detects COVID-19 in a few minutes
In mid-April 2021, a military research laboratory USA DARPA developed an implantable under the skin that chip can be continuously tested for blood new strains of coronavirus and notify the owner of the infection within a few minutes. According to the researchers, the development is going through a late stage of testing and will be used by sailors. More. here
Testing launched to identify T-cell immunity to SARS-CoV-2 coronavirus
On April 8, 2021, it became known about the introduction of testing for patients to determine the T-cell immune status in relation to certain antigens of the SARS-CoV-2 coronavirus. Read more here.
On the portal of the Ministry of Health of Russia posted an interactive educational module on the diagnosis and treatment of COVID-19 for doctors
Interactive educational module (IOM) "Prevention, diagnosis and treatment of a new coronavirus infection"implemented MKNC named after A.S. Loginova on the basis of educational the MedX.pro portal is posted on the medical continuous and - pharmaceutical formations Ministry of Health of Russia edu.rosminzdrav.ru. portal The portal announced this on February 24, 2021. More. here
ReadSense has developed a test system to determine various strains of SARS-CoV-2
Startups ReadSense TechnoSpark Investment Network Groups Infrastructure and Educational Programs Fund (FIOP) Rusnano"" has developed a genetic test system capable of determining not only the presence of coronavirus infection, but also a specific strain of SARS-CoV-2. The first pilot batches will be ready for supply to research laboratories in the nearest future. Rusnano reported this on February 11, 2021. Read more here.
Announcement of the Health Monitor device for diagnosing COVID-19 by breathing
On February 11, 2021, it became known about the preparation of certification of the Health Monitor device designed to detect the COVID-19 coronavirus in humans by exhalation. The device was developed by scientists from the Institute of Automation and Electrometry (IAiE) SB RAS together with ScientificCoin. Read more here.
Sberbank has developed an algorithm that determines by voice, cough and breathing the likelihood of COVID-19 disease
The laboratory artificial intelligence Sberbank has developed one algorithm that can determine the likelihood of infection within 60 seconds coronavirus. COVID-19 The presence of the virus is determined based on the results of a short survey on symptoms and three sound models - voices breathing and coughing. Sberbank announced this on January 12, 2021. More. here
Diagnovir Announcement - COVID-19 Detection Devices
In early January 2021, Bilkent University presented a device for the rapid diagnosis of the coronavirus COVID-19. A device called Diagnovir detects SARS-CoV-2 in saliva samples in an average of 10 seconds with an accuracy of 99%, the developers say. The product was created as a result of cooperation between Bilkent Holding and technology company EA Teknoloji. Read more here.
2020
DarwinAI and Red Hat intend to accelerate the introduction of COVID-Net AI in hospitals to triage patients with COVID-19
On November 25, 2020, it became known that DarwinAI, working in the field of Explainable Artificial Intelligence (XAI), and Red Hat, an open source solution provider, announced a collaboration to accelerate the deployment of the COVID-Net system in hospitals and other medical institutions, a set of deep learning neural networks for detecting COVID-19 and risk stratification through chest X-ray. Read more here.
Test results for COVID-19 are now uploaded to Public services
Ministry of Digital Development, Communications and Mass Media of the Russian Federation November 25, 2020 announced the launch together Rospotrebnadzor Single portal of public services with a service related to prevention. COVID-19 Now the results of tests for coronavirus will be uploaded to the user's personal account on Public services. Portal users who have passed tests in laboratories integrated with the Rospotrebnadzor information system will be able to receive notifications on the readiness of results on Public services. The results themselves will be loaded as in QR code. "" mobile application Public services Stopkoronavirus More. here
Dogs appeared at Helsinki airport, sniffing out infected with COVID-19 with an accuracy of "almost 100%"
At the end of September 2020, it became known that specially trained dogs appeared at the Helsinki airport to detect people who are carriers of the COVID-19 coronavirus. Finnish researchers claim that the accuracy of the determination is "almost 100%." Read more here.
Domodedovo Airport, together with RDIF, launched express testing for COVID-19
Moscow Domodedovo Airport RDIF and on August 21, 2020, they announced the launch of an express testing service at. COVID-19 Everyone can pass the analysis medical at the terminal point. More. here
A court in Moscow sentenced fraudsters who sold fake coronavirus tests to suspended sentences
On August 17, the Savelovsky court Moscow sentenced fraudsters who sold fake tests to suspended sentences. coronavirus COVID-19 Maxim Lavrov, Elvira Kopylova and Ekaterina Lysenkova were found guilty of attempted major fraud, reports "" Interfax with reference to the verdict.
Swindlers posted an ad on Avito with an offer to purchase rapid tests for coronavirus. They agreed to sell 350 drugs to the responding buyer, who, realizing that he was being deceived, turned to the anti-corruption headquarters of the capital's Ministry of Internal Affairs.
The attackers were detained in early April 2020 while trying to sell fake coronavirus tests for 2 thousand rubles. apiece for a total of 700 thousand rubles.
The police found that the attackers were selling vacuum disposable blood sample tubes containing an unknown substance, according MINISTRY OF INTERNAL AFFAIRS to an April 2020 report.
A criminal case has been instituted against the detainees under Art. 30 (preparation for a crime and attempted crime) and Art. 159 (fraud) of the Criminal Code. Since the beginning of April, they have been under recognizance not to leave.
All persons involved in the case pleaded guilty. At their request, the court considered the criminal in a special order - without examining the evidence. The convicts were sentenced to suspended imprisonment for a year with a probationary period of two years. The verdict was passed on June 11, 2020, it entered into force.
Against the background of the coronavirus epidemic, cases of fraud with fake tests for coronavirus have become more frequent in the world. At the end of March, in particular, on the illegal supply of low-quality drugs and fake rapid tests for diagnosing coronavirus to the country. By August 18, 2020 Russia , almost 33 million tests for COVID-19 were carried out, according to data. Rospotrebnadzor[2]
A simulator has been created in Russia for doctors to work out the procedure for diagnosing coronavirus
On August 7, 2020, it became known that an interactive simulator for doctors to work with patients with coronavirus infection will begin work in the system of advanced training of MedX.pro doctors and on the website of the Moscow City Clinical Hospital No. 15 named after O.M. Filatova. Read more here.
Sheremetyevo launched express testing of passengers for coronavirus
On July 20, 2020, express testing of passengers for coronavirus COVID-19 was launched at Sheremetyevo Airport. Arriving and departing travelers can get a result in 1 hour. Read more here.
Sberbank is introducing an AI model for diagnosing coronavirus at the N.N. Priorova National Medical Research Center
On July 15, 2020 Sberbank , he announced that, within the framework of research cooperation, he had signed FSBI "Scientific Medical Research Center for Traumatology and Orthopedics named after N.N. Priorov" Ministry of Health Russia an agreement on the free connection medical of the institution to the developed bank model (), artificial intelligence AI which has already proven itself to be a reliable assistant to doctors in diagnosing coronavirus infection. More. here
Sberbank's free AI service will help identify changes in the lungs, including in COVID-19
The SberHealth service and the SberCloud cloud platform, part of the Sberbank ecosystem, launched a joint project on July 14, 2020 to recognize lung computed tomography images. The service as a whole will help to find out if there are changes in the lungs characteristic of pneumonia, including in COVID-19. Read more here.
VkusVill began selling rapid tests for antibodies to coronavirus
In July 2020, VkusVill began selling rapid tests for antibodies to the coronavirus COVID-19. The retailer offers a set from the Swiss Spring Healthcare at a price of 2.9 thousand rubles. Read more here.
Diagnostics of COVID-19 in Ivanovo are carried out on a computed tomograph using AI
Diagnostics of COVID-19 in Ivanovo are carried out on a computed tomograph with using artificial intelligence technologies. This was announced on July 7, 2020 by Care Mentor AI. Read more here.
The first version of the Celsus neural network for diagnosing COVID-19 has been developed
The team, Medical System Screening (Celsus) the developer of the ""system, Cels completed the development of the first version of the system for analyzing CT lung studies and identifying signs coronavirus of the SARS-COV-2 type on them. This became known on July 6, 2020. More. here
The Government of the Russian Federation allocated 3.5 billion rubles for the production of tests for coronavirus for state institutions
On June 29, 2020, Russian Prime Minister Mikhail Mishustin, during a meeting with Deputy Prime Ministers, announced that the Russian Government had allocated 3.5 billion rubles to Rospotrebnadzor from the reserve fund for the production of tests for coronavirus COVID-19. They will be used in state and municipal institutions. Read more here.
Express test for COVID-19 with biochip created in Russia
On June 15, 2020, it became known about the creation of an express test for COVID-19 in Russia. He uses biochip and is able to detect coronavirus in a person in 10 minutes. Read more here.
Moscow began to pay companies to test employees for coronavirus
From June 11, 2020, Moscow began paying companies to test employees for the COVID-19 coronavirus. Metropolitan organizations can choose a clinic for research, said Anastasia Rakova, Deputy Mayor of Moscow for Social Development, whose words are quoted on the official website of the capital's mayor.
 | We are starting to implement a public-private project with employers, within the framework of which the organization can choose a convenient medical institution on the website of the Health Department, conclude a blood collection agreement with it, and the subsequent study is carried out entirely at the expense of the city, "she said. |  |
According to Rakova, the service was tested for three days, during which time all mechanisms were worked out with employers. Before the launch of the technology, 27 thousand employees of 34 enterprises of the urban economy were tested.
If the employer chooses a clinic, the company's employees must come there strictly by the appointed time, taking with them a passport and a policy of Campus Management compulsory medical insurance. At the entrance, the temperature will be measured, masks, shoe covers will be issued and sent to the paperwork zone.
If testing is carried out on the territory of the organization, a medical team will arrive at the appointed time. Blood will be taken after filling out all the necessary documents.
The results will appear within three days in the electronic medical record. In addition, each organization will select a responsible employee who will also have access to the results, if the rest of the employees agree to this.
| | This project is also open to private medical organizations that want to take part. To do this, you need to submit an application on the website of the Department of Health, - said Anastasia Rakova. | |
By June 11, 2020, everyone can also be tested for antibodies to COVID-19 in Moscow. You can do the test in 30 polyclinics by appointment.[3]
Sberbank has begun industrial implementation of an AI model for diagnosing coronavirus in the regions
On May 22, 2020, Sberbank announced that it had entered into agreements with the Krasnoyarsk Territory and Kuzbass for the free connection of regional clinics to the artificial intelligence ( AI ) model developed by the bank, which could become an assistant to doctors in the diagnosis and treatment of coronavirus. Read more here.
Russia has created a mobile complex for the rapid diagnosis of COVID-19
On May 21, 2020, Zdrav.Expert became known that a device for the rapid diagnosis of COVID-19 from the Electron company was presented in St. Petersburg, this is a computed tomography module. It can be installed on the territory of any medical institution. Read more here.
Nvidia Clara platform replenished with AI models to detect COVID-19
On May 14, 2020, NVIDIA announced the expansion of the platform for healthcare tasks NVIDIA Clara to help the medical community better diagnose and treat COVID-19. Read more here.
Rapid tests for coronavirus from Abbott show false results in half of cases
In mid-May 2020, the results of a new study became known, according to which rapid tests on coronavirus COVID-19 from Abbott show false results in almost half of the cases. More. here
The United States leads in the total number of tests
Online testing of Sberbank for Covid-19 was carried out by residents of all regions of Russia
On April 23, 2020, Sberbank announced that in two weeks from the launch of the free online test Sber COVID-19 symptom checker, more than 135 thousand people passed it. An online survey was conducted by residents of all constituent entities of the Russian Federation - from the Kaliningrad region to the Primorsky Territory - including 35 thousand people from Moscow and more than five thousand from St. Petersburg. Read more here.
The decision based on AI from the "Third Opinion" will help doctors in the diagnosis of COVID-19
The company "Platform Third Opinion - PTM," a resident of the Skolkovo Foundation, as part of the fight against the coronavirus COVID-19, presented on April 20, 2020 a module for recognizing signs of viral pneumonia, as well as an automatic blood analyzer. Development implementation is expected in the second quarter of 2020. Read more here.
Yandex launches home testing for coronavirus for everyone
On April 20, 2020, Yandex announced the start of free testing for a new type of coronavirus for everyone as part of its Help Nearby social project. At the time of launch of the service, it is available only to residents of Moscow and the Moscow region, but the company promises to expand its geographical coverage throughout Russia. Read more here.
Rostelecom presented a solution for remote recognition of signs of coronavirus
On April 17, 2020, Rostelecom announced the development of a prototype service for recognizing the signs of coronavirus (COVID-19) from X-ray images of the lungs. The service works on the basis of a radiological information system in which X-rays are accumulated. The technology can be used to quickly detect symptoms of infection and take urgent measures. Read more here.
Rosatom began sterilizing medical transport systems for coronavirus tests
On April 16, 2020 Zdrav.Expert , it became known that JSC "" Sterion(a subsidiary of the state corporation "," Rosatom part of the management loop of JSC Rusatom Healthcare""), as part of the implementation of the contract with the company "," GEM began to sterilize medical transport the systems necessary for testing for the presence of the virus. COVID-19 More. here
Gazprom Neft tested more than 50% of its employees for COVID-19
On April 15, 2020, Gazprom Neft announced the completion of the first stage of mass preventive testing for COVID-19, which covered employees of the company and contractors involved in ensuring continuous production in industrial regions of activity. Read more here.
Italy and Russia lead in the number of tests per 1000 people
Sberbank created a free online test for coronavirus
On April 13 Sberbank , 2020, he announced Zdrav.Expert an offer to everyone to pass free of charge, тест Sber Covid-19symptom checker which allows you to quantify the likelihood of the disease, coronavirus as well as the likelihood of a mild course of the disease. More. here
A large number of errors in negative tests. CT is recommended
As of mid-April 2020, with negative tests for coronavirus, a large number of errors and only CT scans show the real situation.
As soon as a combination of signs appears: fever, body pain, even the absence of cough - this is most likely COVID-19.
Without panic, go and go to the hospital, preferably specialized. It will save your lives. If you find and decide to admit that you are sick in time, the disease will not be so severe.
Immediately do a general blood test and CT scan, and take antiviral drugs to slow down the development of the disease.
FMBA Research and Clinical Center presented reagents to the Indicator-Bio analyzer to detect COVID-19 in 15 minutes
On April 10, 2020, the Federal Scientific and Clinical Center for Physical and Chemical Medicine (FNCC FKM) of the Federal Medical and Biological Agency (FMBA) presented chips and reagents for the Indicator-BIO analyzer. They allow you to identify dangerous viruses in biological fluids in 15 minutes, including the COVID-19 coronavirus. The Indicator-BIO device was developed by specialists from the Troitsky Engineering Center company, which is part of the TechnoSpark Group, a subsidiary of the Infrastructure and Educational Programs Fund (FIOP) of the RUSNANO Group. Read more here.
Care Mentor AI develops AI for prompt diagnosis of COVID-19
On April 8, 2020, the company Care Mentor AI (CareMentorAI) announced that it is developing a system Artificial Intelligence that will speed up the analysis of the review roentgenograms chest CT and patients with suspected viral pneumonia, which, as of April 2020, taking into account the epidemiological situation, is caused in most cases. coronavirus More. here
"Medical and Biological Union" launched the production of rapid tests for COVID-19
On April 7, 2020, Akadempark announced that his resident of the Medical and Biological Union Group of Companies had launched the production of an express coronavirus test based on his own innovative developments. Read more here.
"Invitro" changed her mind about testing for coronavirus due to fear for the health of employees
On April 7, 2020, Invitro the private medical company "" announced the rejection of the idea of taking tests for. coronavirus COVID-19 Instead, the decision was made to accept the assays as a centralized laboratory. More. here
Vocalis Health has developed technology for diagnosing COVID-19 by voice
On April 6, 2020, the company Vocalis Health announced that it had developed COVID-19 coronavirus diagnosis technology based on analysis of the voice spectrum. As of April 2020 Israel , the procedure for recording the votes of patients with an identified diagnosis coronavirus of infection began. The technology is based on the patented developments of Beyond Verbal, recognitions and the processing of voice data to medicine in using technologies (). artificial intelligence AI More. here
Rospotrebnadzor began conducting paid tests for coronavirus at home. Anyone can pass it
On April 6, 2020 Rospotrebnadzor , he began conducting paid tests at coronavirus COVID-19 home. Anyone can pass it, but not anonymously. The cost of the service is 1900. rubles
Mass testing for a new type of coronavirus was launched by the Center for Molecular Diagnostics of Rospotrebnadzor. By April 6, 2020, the service is available only in Moscow and the Moscow region, but in the future it will cover all regions.
A specialist of the field service of the Center for Molecular Diagnostics with a diagnostic kit will come to those wishing to pass the home test. He will instruct how to take a swab from the oropharynx on his own and take the biomaterial container away for research. The result will be presented within one to two days by e-mail.
You can take an analysis without a doctor's prescription. To check for coronavirus, the Center for Molecular Diagnostics uses a test system developed by scientists from the Central Research Institute of Epidemiology.
The Center for Molecular Diagnostics itself clarifies that the test is intended for everyone. But there are limitations: the patient should not have signs of colds, and there were no contacts with people infected with COVID-19.
The test system meets modern European requirements, it can detect infection in the early stages of the disease, as well as in people with non-pronounced symptoms. With the help of tests, the main principle of combating the epidemic "identify, disconnect, treat" will be implemented, the Rospotrebnadzor said in a statement.
Rospotrebnadzor intends to conduct a study on the number of Russians who have already received immunity to coronavirus, said the head of the department Anna Popova. According to her, a population study was planned and developed - "you need to understand what is being done in the population, where it was very widespread, in Moscow and the Moscow region, and where there was not yet a virus at all, how it is protected and how the population is not protected."[4]
Medtronic launches new program for self-monitoring of COVID-19 symptoms
In early April 2020, Medtronic launched a new program to independently monitor the symptoms of a new type of coronavirus COVID-19. The initiative was called MCMS COVID-19. Read more here.
Skolkovo resident opened free access to the pneumonia severity assessment system
On April 3, 2020, Skolkovo the Foundation "" announced that the company K-Skye"," a resident of biomedical the Skolkovo Foundation's Technology Cluster, provided free access medical to information system developers and medical organizations to the predictive analytics and risk management platform based on. artificial intelligence Webiomed
During the COVID-19 pandemic, it is vital to timely diagnosis and determine further medical actions: whether the patient needs hospitalization, whether he can be in a regular ward or needs resuscitation. To solve this important issue, about twenty patient health indicators are used, combined into several scales of pneumonia severity. Read more here.
Skolkovo began to produce reagent kits for rapid tests for COVID-19
On April 1, 2020, the Skolkovo Foundation announced the start of the production of reagent kits for rapid tests for COVID-19. Read more here.
Roszdravnadzor issued 7 companies permission to produce coronavirus-detecting test systems
On March 30, 2020, it became known that Roszdravnadzor it had issued permission to seven Russian companies to produce detection coronavirus COVID-19 test systems.
| | In fact, all consideration of applications takes place within one to two days, and manufacturers from Friday [March 27, 2020 - approx. TAdviser] have already begun production of additional test systems, including a reduction in the pre-analytical stage, - said Minister of Health Mikhail Murashko at a meeting of the Presidium of the Coordination Council to combat the spread of COVID-19 in the Russian Federation. | |
Roszdravnadzor registered two test systems for COVID-19 using the polymerase chain reaction method - the development of one of the largest manufacturers of laboratory reagents of the Novosibirsk JSC Vector-Best, as well as the Moscow LLC NPF Litech. In addition, the registration certificate for the diagnostic production system of the Ministry of Health of the Russian Federation has been updated - in addition to the subordinate Center for Strategic Planning (CSP ), it will be produced by DNA-Technologies TS LLC and the pharmaceutical company Generium JSC.
It is argued that the test of Vector-Best JSC is distinguished by high sensitivity - 1x103 copies per milliliter of the original sample, it is planned to start the release of diagnostic systems this week. It is assumed that the production capacity will be 1 thousand test systems with a set of reagents for 100 analyzes, which will allow up to 100 thousand studies per week.
At the end of March 2020 , the Federal State Budgetary Institution "Center for Strategic Planning and Management of Biomedical Health Risks" launched mass production of a test system for detecting the RNA of the SARS-CoV-2 coronavirus of severe acute respiratory syndrome (COVID-19) by the polymerase chain reaction method "AmpliTest SARS-CoV-2.[5]
The new test system differs from its counterparts in its higher sensitivity. Subsequently, production is planned to increase from 10 thousand to 50 thousand tests per day.
Rostec and RDIF create a portable laboratory for rapid tests for coronavirus
On March 30, 2020, it became known about the creation by Rostec and the Russian Direct Investment Fund (RDIF) of a portable laboratory for rapid tests for the coronavirus COVID-19. Read more here.
Innopolis University has developed a method for diagnosing coronavirus from medical images with an accuracy of 80%
On March 26, 2020, Innopolis University reported that employees of the Russian Center for Artificial Intelligence trained the neural network on 28 thousand medical images with pneumonia, including 94 images taken from patients with COVID-19. Employees of the center are preparing to launch an online service that will help doctors quickly identify patients with developed coronavirus pneumonia during mass diagnostics around the world. Read more here.
Bosch has developed a test that diagnoses coronavirus in 2.5 hours
On March 26, 2020, Bosch announced the development of a rapid test, which, according to the company, allows the body to be diagnosed with the Covid-19 coronavirus in 2.5 hours. Read more here.
Botkin.AI has functionality for analyzing pneumonia in order to improve the diagnosis of coronavirus infection
On March 25, 2020 Skolkovo Foundation , he announced that his resident the Russian company "" Intellojik promptly developed and added Botkin.AI functionality to the platform for analyzing pneumonia. The company expects that this will reduce the risks and mitigate the possible consequences of the epidemic. coronavirus COVID-19 More. here
The Government of the Russian Federation allocated 1.4 billion rubles for the development of means of prevention and diagnosis of coronavirus
On March 25, 2020, the Government of the Russian Federation announced the allocation of budget allocations to Rospotrebnadzor from the reserve fund for the development of means for the prevention and diagnosis of a new coronavirus infection. The corresponding order was signed by Prime Minister Mikhail Mishustin.
Rospotrebnadzor must monitor the targeted and effective use of the allocated funds and report this to the government by February 1, 2021.
Earlier, the prime minister instructed the Ministry of Finance and the Ministry of Economic Development to determine by March 26 budget expenditures, which they consider priority in a pandemic. Some spending has already lost its relevance, and you need to find money to support the economy and social sphere without resorting to a general reduction in spending, the Ministry of Finance told Vedomosti.
According to the interlocutor of the publication, social expenses will not be reduced, but the priority is to support the population and especially badly affected businesses, including small and medium-sized ones.
Earlier, Rospotrebnadzor was allocated 1.618 billion rubles for additional payments to persons working "in an enhanced mode in connection with the measures taken to prevent the import and spread of a new coronavirus infection." For similar purposes, the Ministry of Health of the Russian Federation allocated 10.223 billion rubles.
According to the statement of Rospotrebnadzor, the introduction of a domestic vaccine against COVID-19 may occur in the fourth quarter of 2020. By March 25, 2020, prototypes of drugs are undergoing laboratory tests.
Since March 24, Rospotrebnadzor has changed the scheme for confirming research results for COVID-19. Biomaterial of studies suspicious of COVID-19 from laboratories in the regions of the Central, North-West, Volga and North Caucasus Federal Districts will be sent for final confirmation to a specially equipped reference center based on the Anti-Plague Center of Rospotrebnadzor in Moscow.[6]
National Bioservice provides accelerated testing of anti-coronavirus drugs and test systems
The portfolio company of the RVC BioFund "National BioService" (NBS) has provided the opportunity for accelerated testing of anti-coronavirus drugs and test systems that Russian developers are working on. Shortening the time of preclinical studies and technical tests will be possible through the use of tissue microchips. This was announced on March 24, 2020 by RVC. Read more here.
Abbott urgently allowed to supply coronavirus tests
In mid-March 2020, Abbott received emergency approval from regulators to supply a molecular test for the new coronavirus (COVID-19). Read more here.
Coronavirus test created showing result in 30 minutes
On March 18, 2020 Oxford University , they announced the creation of an express test for the detection of coronavirus COVID-19 infection. According to scientists, their development produces results about three times faster than other testing methods.
It is claimed that the test created by Oxford researchers determines the presence or absence of a new coronavirus in the human body in half an hour. In doing so, other methods that focus on viral RNA, like this one, produce results within 1.5-2 hours.
In addition, according to its creators, the test can identify patients infected with coronavirus, even in the early stages of infection.
To achieve such an impressive result, the researchers had to change the technology for processing the viral genome. During most tests, the isolated RNA is converted into DNA and only then tested using special enzymes and expensive equipment. However, simpler devices are enough for the Oxford test. In addition, its result is easier to interpret.
| | The beauty of this new test lies in the development of a virus detection system that can specifically recognize fragments of human RNA and COVID-19 RNA. The test has built-in checks to prevent false positives or negative results, and the results were very accurate, Professor Wei Huang stated. | |
The rapid test from the University of Oxford was tested using real clinical samples of the virus at Shenzhen People's Hospital in. China The team that developed it is also working on the possibility of making it even more accessible, which will allow it to be "used in clinics, airports or even for home use," the publication reports. TechCrunch
AFK Sistema has developed an express test for coronavirus. The result is known in 2 hours
On March 19, 2020, it became known that AFK Sistema the company "" Sistema-Biotech developed an express test for coronavirus a new type of COVID-19 and intends to submit to Rospotrebnadzor the registration dossier for development in the near future. More. here
RDIF invests in the production of rapid tests for coronavirus
On March 16, 2020, the Russian Direct Investment Fund (RDIF) announced its investment in the production of systems for the rapid diagnosis of coronavirus infection COVID-19. Read more here.
New coronavirus test approved
In mid-March 2020, the Food and Drug Administration (FDA) approved a new coronavirus test that will speed up patient testing tenfold. Read more here.
Notes
- ↑ In Astrakhan, the ex-director of the company received a suspended sentence in the case of tests for covid
- ↑ Fraudsters condemned in Moscow for selling fake tests for coronavirus
- ↑ Employers will be able to test employees for antibodies to coronavirus
- ↑ Contactless testing for coronavirus opened at the Center for Molecular Diagnostics of Rospotrebnadzor
- ↑ Seven Russian companies received permission to produce tests for coronavirus
- ↑ An order was signed on the allocation of budget allocations to Rospotrebnadzor from the Government reserve fund for the development of means of prevention and diagnosis of a new coronavirus infection
- ↑ Oxford scientists develop new coronavirus test
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |